The activation of the transcription factor NRF2 (Nuclear factor Erythroid 2-related Factor 2) counteracts many of the pathological processes occurring in neurodegenerative diseases [1,2,3]. The gene discussed is NFE2L2; the disease is neurodegenerative disease.